Population-based tobacco treatment: Study design of a randomized controlled trial

Steven S. Fu, Michelle Van Ryn, Scott Sherman, Diana J. Burgess, Siamak Noorbaloochi, Barbara Clothier, Anne M. Joseph

Research output: Contribution to journalArticle

Abstract

Background. Most smokers do not receive comprehensive, evidence-based treatment for tobacco use that includes intensive behavioral counseling along with pharmacotherapy. Further, the use of proven, tobacco treatments is lower among minorities than among Whites. The primary objectives of this study are to: (1) Assess the effect of a proactive care intervention (PRO) on population-level smoking abstinence rates (i.e., abstinence among all smokers including those who use and do not utilize treatment) and on utilization of tobacco treatment compared to reactive/usual care (UC) among a diverse population of smokers, (2) Compare the effect of PRO on population-level smoking abstinence rates and utilization of tobacco treatments between African American and White smokers, and (3) Determine the cost-effectiveness of the proactive care intervention. Methods/Design. This prospective randomized controlled trial identifies a population-based sample of current smokers from the Department of Veterans Affairs (VA) electronic medical record health factor dataset. The proactive care intervention combines: (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or face-to-face). Proactive outreach includes mailed invitation materials followed by an outreach call that encourages smokers to seek treatment with choice of services. Proactive care participants who choose telephone care receive VA telephone counseling and access to pharmacotherapy. Proactive care participants who choose face-to-face care are referred to their VA facility's smoking cessation clinic. Usual care participants have access to standard smoking cessation services from their VA facility (e.g., pharmacotherapy, smoking cessation clinic) and from their state telephone quitline. Baseline data is collected from VA administrative databases and participant surveys. Outcomes from both groups are collected 12 months post-randomization from participant surveys and from VA administrative databases. The primary outcome is self-reported smoking abstinence, which is assessed at the population-level (i.e., among those who utilize and those who do not utilize tobacco treatment). Primary analyses will follow intention-to-treat methodology. Discussion. This randomized trial is testing proactive outreach strategies offering choice of smoking cessation services, an innovation that if proven effective and cost-effective, will transform the way tobacco treatment is delivered. National dissemination of proactive treatment strategies could dramatically reduce tobacco-related morbidity, mortality, and health care costs. Clinical trials registration. ClinicalTrials.gov: NCT00608426.

Original languageEnglish (US)
Article number159
JournalBMC Public Health
Volume12
Issue number1
DOIs
StatePublished - Mar 7 2012

Fingerprint

Tobacco
Randomized Controlled Trials
Veterans
Smoking Cessation
Population
Telephone
Therapeutics
Smoking
Tobacco Use
Drug Therapy
Counseling
Databases
Electronic Health Records
Random Allocation
African Americans
Health Care Costs
Cost-Benefit Analysis
Clinical Trials
Morbidity
Costs and Cost Analysis

Keywords

  • Ethnic Groups
  • Minority Health
  • Smoking Cessation
  • Tobacco Cessation Products

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Fu, S. S., Van Ryn, M., Sherman, S., Burgess, D. J., Noorbaloochi, S., Clothier, B., & Joseph, A. M. (2012). Population-based tobacco treatment: Study design of a randomized controlled trial. BMC Public Health, 12(1), [159]. https://doi.org/10.1186/1471-2458-12-159

Population-based tobacco treatment : Study design of a randomized controlled trial. / Fu, Steven S.; Van Ryn, Michelle; Sherman, Scott; Burgess, Diana J.; Noorbaloochi, Siamak; Clothier, Barbara; Joseph, Anne M.

In: BMC Public Health, Vol. 12, No. 1, 159, 07.03.2012.

Research output: Contribution to journalArticle

Fu, SS, Van Ryn, M, Sherman, S, Burgess, DJ, Noorbaloochi, S, Clothier, B & Joseph, AM 2012, 'Population-based tobacco treatment: Study design of a randomized controlled trial', BMC Public Health, vol. 12, no. 1, 159. https://doi.org/10.1186/1471-2458-12-159
Fu, Steven S. ; Van Ryn, Michelle ; Sherman, Scott ; Burgess, Diana J. ; Noorbaloochi, Siamak ; Clothier, Barbara ; Joseph, Anne M. / Population-based tobacco treatment : Study design of a randomized controlled trial. In: BMC Public Health. 2012 ; Vol. 12, No. 1.
@article{f06f7d1600054273802d3705bd046afc,
title = "Population-based tobacco treatment: Study design of a randomized controlled trial",
abstract = "Background. Most smokers do not receive comprehensive, evidence-based treatment for tobacco use that includes intensive behavioral counseling along with pharmacotherapy. Further, the use of proven, tobacco treatments is lower among minorities than among Whites. The primary objectives of this study are to: (1) Assess the effect of a proactive care intervention (PRO) on population-level smoking abstinence rates (i.e., abstinence among all smokers including those who use and do not utilize treatment) and on utilization of tobacco treatment compared to reactive/usual care (UC) among a diverse population of smokers, (2) Compare the effect of PRO on population-level smoking abstinence rates and utilization of tobacco treatments between African American and White smokers, and (3) Determine the cost-effectiveness of the proactive care intervention. Methods/Design. This prospective randomized controlled trial identifies a population-based sample of current smokers from the Department of Veterans Affairs (VA) electronic medical record health factor dataset. The proactive care intervention combines: (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or face-to-face). Proactive outreach includes mailed invitation materials followed by an outreach call that encourages smokers to seek treatment with choice of services. Proactive care participants who choose telephone care receive VA telephone counseling and access to pharmacotherapy. Proactive care participants who choose face-to-face care are referred to their VA facility's smoking cessation clinic. Usual care participants have access to standard smoking cessation services from their VA facility (e.g., pharmacotherapy, smoking cessation clinic) and from their state telephone quitline. Baseline data is collected from VA administrative databases and participant surveys. Outcomes from both groups are collected 12 months post-randomization from participant surveys and from VA administrative databases. The primary outcome is self-reported smoking abstinence, which is assessed at the population-level (i.e., among those who utilize and those who do not utilize tobacco treatment). Primary analyses will follow intention-to-treat methodology. Discussion. This randomized trial is testing proactive outreach strategies offering choice of smoking cessation services, an innovation that if proven effective and cost-effective, will transform the way tobacco treatment is delivered. National dissemination of proactive treatment strategies could dramatically reduce tobacco-related morbidity, mortality, and health care costs. Clinical trials registration. ClinicalTrials.gov: NCT00608426.",
keywords = "Ethnic Groups, Minority Health, Smoking Cessation, Tobacco Cessation Products",
author = "Fu, {Steven S.} and {Van Ryn}, Michelle and Scott Sherman and Burgess, {Diana J.} and Siamak Noorbaloochi and Barbara Clothier and Joseph, {Anne M.}",
year = "2012",
month = "3",
day = "7",
doi = "10.1186/1471-2458-12-159",
language = "English (US)",
volume = "12",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Population-based tobacco treatment

T2 - Study design of a randomized controlled trial

AU - Fu, Steven S.

AU - Van Ryn, Michelle

AU - Sherman, Scott

AU - Burgess, Diana J.

AU - Noorbaloochi, Siamak

AU - Clothier, Barbara

AU - Joseph, Anne M.

PY - 2012/3/7

Y1 - 2012/3/7

N2 - Background. Most smokers do not receive comprehensive, evidence-based treatment for tobacco use that includes intensive behavioral counseling along with pharmacotherapy. Further, the use of proven, tobacco treatments is lower among minorities than among Whites. The primary objectives of this study are to: (1) Assess the effect of a proactive care intervention (PRO) on population-level smoking abstinence rates (i.e., abstinence among all smokers including those who use and do not utilize treatment) and on utilization of tobacco treatment compared to reactive/usual care (UC) among a diverse population of smokers, (2) Compare the effect of PRO on population-level smoking abstinence rates and utilization of tobacco treatments between African American and White smokers, and (3) Determine the cost-effectiveness of the proactive care intervention. Methods/Design. This prospective randomized controlled trial identifies a population-based sample of current smokers from the Department of Veterans Affairs (VA) electronic medical record health factor dataset. The proactive care intervention combines: (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or face-to-face). Proactive outreach includes mailed invitation materials followed by an outreach call that encourages smokers to seek treatment with choice of services. Proactive care participants who choose telephone care receive VA telephone counseling and access to pharmacotherapy. Proactive care participants who choose face-to-face care are referred to their VA facility's smoking cessation clinic. Usual care participants have access to standard smoking cessation services from their VA facility (e.g., pharmacotherapy, smoking cessation clinic) and from their state telephone quitline. Baseline data is collected from VA administrative databases and participant surveys. Outcomes from both groups are collected 12 months post-randomization from participant surveys and from VA administrative databases. The primary outcome is self-reported smoking abstinence, which is assessed at the population-level (i.e., among those who utilize and those who do not utilize tobacco treatment). Primary analyses will follow intention-to-treat methodology. Discussion. This randomized trial is testing proactive outreach strategies offering choice of smoking cessation services, an innovation that if proven effective and cost-effective, will transform the way tobacco treatment is delivered. National dissemination of proactive treatment strategies could dramatically reduce tobacco-related morbidity, mortality, and health care costs. Clinical trials registration. ClinicalTrials.gov: NCT00608426.

AB - Background. Most smokers do not receive comprehensive, evidence-based treatment for tobacco use that includes intensive behavioral counseling along with pharmacotherapy. Further, the use of proven, tobacco treatments is lower among minorities than among Whites. The primary objectives of this study are to: (1) Assess the effect of a proactive care intervention (PRO) on population-level smoking abstinence rates (i.e., abstinence among all smokers including those who use and do not utilize treatment) and on utilization of tobacco treatment compared to reactive/usual care (UC) among a diverse population of smokers, (2) Compare the effect of PRO on population-level smoking abstinence rates and utilization of tobacco treatments between African American and White smokers, and (3) Determine the cost-effectiveness of the proactive care intervention. Methods/Design. This prospective randomized controlled trial identifies a population-based sample of current smokers from the Department of Veterans Affairs (VA) electronic medical record health factor dataset. The proactive care intervention combines: (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone or face-to-face). Proactive outreach includes mailed invitation materials followed by an outreach call that encourages smokers to seek treatment with choice of services. Proactive care participants who choose telephone care receive VA telephone counseling and access to pharmacotherapy. Proactive care participants who choose face-to-face care are referred to their VA facility's smoking cessation clinic. Usual care participants have access to standard smoking cessation services from their VA facility (e.g., pharmacotherapy, smoking cessation clinic) and from their state telephone quitline. Baseline data is collected from VA administrative databases and participant surveys. Outcomes from both groups are collected 12 months post-randomization from participant surveys and from VA administrative databases. The primary outcome is self-reported smoking abstinence, which is assessed at the population-level (i.e., among those who utilize and those who do not utilize tobacco treatment). Primary analyses will follow intention-to-treat methodology. Discussion. This randomized trial is testing proactive outreach strategies offering choice of smoking cessation services, an innovation that if proven effective and cost-effective, will transform the way tobacco treatment is delivered. National dissemination of proactive treatment strategies could dramatically reduce tobacco-related morbidity, mortality, and health care costs. Clinical trials registration. ClinicalTrials.gov: NCT00608426.

KW - Ethnic Groups

KW - Minority Health

KW - Smoking Cessation

KW - Tobacco Cessation Products

UR - http://www.scopus.com/inward/record.url?scp=84857770167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857770167&partnerID=8YFLogxK

U2 - 10.1186/1471-2458-12-159

DO - 10.1186/1471-2458-12-159

M3 - Article

C2 - 22394386

AN - SCOPUS:84857770167

VL - 12

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

M1 - 159

ER -